Sign in

**Brent Shafer**

Interim CEO and Chair of the Board at BAXTER INTERNATIONAL
Board
Since February 3, 2025
Age
67 years
Tenure
Joined the Board in May 2022, served as Lead Independent Director starting April 2023, and was appointed as Interim CEO and Chair of the Board on February 3, 2025.

Also at BAXTER INTERNATIONAL

*S
**Alok Sonig**
EVP and Group President, Pharmaceuticals
*SR
**David S. Rosenbloom**
EVP and General Counsel
*K
**Heather Knight**
EVP and COO

About

Brent Shafer is 67 years old as of 2025, bringing over four decades of experience in the healthcare and medical technology industries. His career has spanned multiple global organizations where he has held senior leadership roles and driven significant strategic transformations.

Initially, he joined Baxter International Inc. as a director in May 2022 and then advanced to the role of Lead Independent Director in April 2023, demonstrating his increasing influence within the company. His appointment as Interim CEO and Chair of the Board on February 3, 2025, marked a pivotal moment in his tenure, as he assumed leadership during a period of strategic transition at Baxter.

Throughout his career, he has steered organizations such as Cerner Corporation and Philips Healthcare, among others, contributing substantially to innovations in health information technologies and operational excellence. His extensive background and leadership acumen have positioned him as a key driver in Baxter’s ongoing transformation.

$BAX Performance Under **Brent Shafer**

Past Roles

OrganizationRoleDate RangeDetails
Baxter International Inc. Lead Independent Director; Audit Committee Member; Nominating, Corporate Governance, and Public Policy Committee Member April 28, 2023 - February 3, 2025 N/A
Cerner Corporation Chair and Chief Executive Officer 2018 - 2021 Health information technologies
Philips Healthcare (Koninklijke Philips NV) Chief Executive Officer of Philips North America; Chief Executive Officer of Philips Home Healthcare Solutions N/A Specializes in diagnostic imaging, patient monitoring, and health informatics
Hillrom (Hill-Rom Holdings, Inc.) Vice President and General Manager of the Patient Care Environment Division N/A Focused on patient care solutions
GE Medical Systems Various key positions in sales, marketing, and general management N/A Specializes in medical imaging and healthcare technologies
Hewlett Packard’s Medical Products Group Senior roles N/A Focus on medical products and healthcare solutions
Johnson & Johnson Senior roles N/A Involved in pharmaceuticals, medical devices, and consumer health products

External Roles

OrganizationRoleDate Range
Tactile Systems Technology, Inc. Director N/A
Veracyte, Inc. Director N/A

Fixed Compensation

Data from  FY 2025
Component NameAmountPayment ScheduleAdditional Details
Base Salary$108,333 per month MonthlyAnnualized during term as Interim CEO/Chair
Legal FeesUp to $30,000 As incurred upon submissionReimbursement for legal fees reasonably incurred in connection with negotiation/documentation of the offer letter

Performance Compensation

Data from  FY 2025

Bonus

MetricDetail
Bonus Amount$600,000
Payment TriggerEarned and payable on the first regular payroll date following the completion of his term
ConditionsContingent upon continuous employment through his term as Interim CEO/Chair

Equity Award (RSUs)

MetricDetail
Grant Value$2,500,000
Grant DateAs soon as administratively practicable after his start date on February 3, 2025
Vesting ScheduleVest upon the end of his term, defined as the earlier of the six-month anniversary (August 3, 2025) or the first employment day of a successor CEO
ConditionsVesting is contingent on his continued employment through the term; no additional performance metrics are specified
Performance MetricsNo detailed performance metrics, thresholds, or specific targets provided

Note: The bonus and RSUs are tied to his tenure as Interim CEO/Chair, and no further performance-based calculations (e.g., thresholds, weights or evaluation periods) are disclosed in the documents.